Global Immunology Summit 2027 – Decoding Human Immunity in Serendip

Decoding Human Immunity in Serendip: From Human Immunology to Global Health


Building on the strong foundation and success of the Global Immunology Summit series established in India, which has brought together leading immunologists and fostered vibrant scientific exchange, the Global Immunology Summit 2027 (GIS 2027) will be held on 12th–13th February 2027 in Colombo, Sri Lanka, bringing together world-leading scientists, clinicians, and emerging investigators for a dynamic exchange of ideas at the frontiers of human immunology.


Set against the vibrant backdrop of Sri Lanka, GIS 2027 will serve as a unique global platform to explore how advances in human immunology, systems immunology, immune profiling, and translational science are transforming our understanding of health and disease. The scientific program will feature keynote lectures, thematic symposia, and interactive discussions spanning cutting-edge areas including systems vaccinology, immune memory and durability, autoimmunity, immunometabolism, host–pathogen interactions, and emerging infectious diseases. A central theme of the meeting will be the integration of multi-omics, computational approaches, and clinical investigation to decode the human immune system and guide next-generation vaccines and immunotherapies.


With a strong emphasis on translation and human biology, the summit will highlight how deep mechanistic insights are driving innovations in disease prevention and treatment across infections, chronic inflammatory diseases, and immune-mediated disorders. The meeting is organized by the Institute of Allergology and Immunology, Sri Lanka, in collaboration with internationally recognized leaders Prof. Neelika Malavige (Sri Lanka), Prof. Amit Awasthi (India), and Prof. Bali Pulendran (Stanford University, USA), ensuring a truly global and interdisciplinary perspective.


The summit will feature an outstanding lineup of global leaders shaping modern immunology, including the following:

Osamu Takeuchi — Graduate School of Medicine, Kyoto University

Amit Awasthi — THSTI, India

Tao Dong — University of Oxford

Ken Ishii — The University of Tokyo

Tae Jin Kim — School of Medicine, Sungkyunkwan University

Sudha Kumari — IISc Bengaluru, India

Andrew McMichael — University of Oxford

Graham Ogg — University of Oxford

Bali Pulendran — Stanford University

Mark Davis — Stanford University

David Hafler — Yale School of Medicine

Ashley St John — Duke-NUS, Singapore

Vijay Kuchroo — Harvard Medical School

Neelika Malavige — IAI, Sri Lanka

Mihai Netea — Radboud University

Shiv Pillai — Harvard Medical School

GIS 2027 will also provide exceptional opportunities for scientific exchange, networking, mentorship, and showcasing innovative research, with dedicated engagement for early-career scientists and trainees. Join us in Colombo for two days of inspiring science, meaningful collaboration, and forward-looking discussions that will shape the future of human immunology. The reference to “Serendip,” an ancient name for Sri Lanka, reflects the spirit of discovery and unexpected insight that drives scientific innovation.